Lipoproteins modulate expression of the macrophage scavenger receptor

American Journal of Pathology

Volumn 152, Issue 6, 1998, Pages 1647-1654

  Han, Jihong ^a   Nicholson, Andrew C ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; SCAVENGER RECEPTOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; FOAM CELL; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BLOTTING, NORTHERN; CELL ADHESION MOLECULES; CELL LINE; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXUDATES AND TRANSUDATES; HALF-LIFE; INJECTIONS, INTRAPERITONEAL; LIPOPROTEINS, LDL; MACROPHAGES; MICE; PERITONEUM; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL; RECEPTORS, SCAVENGER; RNA, MESSENGER; SERUM ALBUMIN, BOVINE;

EID: 0031748833     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Steinberg D: Lipoproteins and the pathogenesis of atherosclerosis. Circulation 1987, 76:508-514
2. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J: Beyond cholesterol: modifications of low-density lipoprotein which increase its atherogenicity. N Engl J Med 1989, 320:915-919
3. Gown A, Tsukada T, Ross R: Human atherosclerosis: II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986, 125:191-207
4. Fogelman A, Van Lenten B, Warden C, Haberland M, Edwards P: Macrophage lipoprotein receptors. J Cell Sci 1988, 9(Suppl):135-149
5. Pearson A, Lux A, Krieger M: Expression cloning of dSR-C1, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc Natl Acad Sci USA 1995, 92:4056-4060
6. Kodama T, Reddy P, Kishamoto C, Krieger M: Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc Natl Acad Sci USA 1988, 85:9238-9242
7. Via D, Dresel H, Cheng S-L, Gotto A: Murine macrophage tumors are a source of a 260,000-dalton acetyl-low density lipoprotein receptor. J Biol Chem 1985, 260:7379-7386
8. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M: Type I macrophage scavenger receptor contains α-helial, and collagen-like coiled coils. Nature 1990, 343:531-535
9. Rohrer L, Freeman M, Kodama T, Penman M, Krieger M: Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 1990, 343:570-572
10. Parthasarathy S, Printz D, Boyd D, Joy L, Steinberg D: Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 1986, 6:505-510
11. Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Cohen E, Wydro R, Housman D, Kodama T: Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci USA 1990, 87:9133-9137
12. Freeman M, Ashkenas J, Rees D, Kingsley D, Copeland N, Jenkins N, Krieger M: An ancient highly conserved family of cysteine-rich protein domains revealed by cloning the type I and type II murine scavenger receptors. Proc Natl Acad Sci USA 1990, 87:8810-8814
13. Bickel P, Freeman M: Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J Clin Invest 1992, 90:1450-1457
14. Hampton R, Golenbock D, Penman M, Krieger M, Raetz C: Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991, 352:342-344
15. Geng Y, Kodama T, Hansson G: Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler Thromb 1994, 14:798-806
16. Fogelman A, Haberland M, Seager J, Hokom M, Edwards P: Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J Lipid Res 1981, 22:1131-1141
17. Via D, Pons L, Dennison D, Fanslow A, Bernini F: Induction of acetyl-LDL receptor activity by phorbol ester in human monocyte cell line THP-1. J Lipid Res 1989, 30:1515-1524
18. Ishibashi S, Inaba T, Shimano H, Herada K, Inoue I, Mokuno H, Mori N, Gotoda T, Takaku F, Yamada N: Monocyte colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophages. J Biol Chem 1990, 265:14109-14117
19. de Villiers WJS, Fraser I, Hughes D, Doyle A, Gordon S: Macrophage-colony stimulating factor selectively enhances macrophage scavenger receptor expression and function. J Exp Med 1994, 180:705-709
20. Van Lentin B, Fogelman A, Seager J, Ribi E, Haberland M, Edwards P: Bacterial endotoxin selectively prevents the expression of scavenger-receptor activity on human monocyte-macrophages. J Immunol 1985, 134:3718-3721
21. Van Lenten B, Fogelman A: Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-α. J Immunol 1992, 148:112-116
22. Hsu HY, Nicholson AC, Hajjar DP: Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-α is transcriptionally and post-transcriptionally regulated. J Biol Chem 1996, 271:7767-7773
23. Fong L, Fong A, Cooper A: Inhibition of mouse macrophage degradation of acetyl-low density lipoprotein by interferon-γ. J Biol Chem 1990, 265:11751-11760
24. Geng Y, Hansson G: Interferon-γ inhibits scavenger receptor expression, and foam cell formation in human monocyte-derived macrophages. J Clin Invest 1992, 89:1322-1330
25. Bottalico L, Wagner R, Agellon L, Assoian R, Tabas I: Transforming growth factor-β 1 inhibits scavenger receptor activity in THP-1 human macrophages. J Biol Chem 1991, 266:22866-22871
26. Moulton K, Wu H, Barnett J, Parthasarathy S, Glass C: Regulated expression of the human acetylated low density lipoprotein receptor gene. Proc Natl Acad Sci USA 1992, 89:8102-8106
27. Fogelman A, Seager J, Haberland M, Hokom M, Tanaka R, Edwards P: Lymphocyte-conditioned medium protects human monocyte-macrophages from cholesteryl ester accumulation. Proc Natl Acad Sci USA 1982, 79:922-926
28. Endemann G, Stanton L, Madden K, Bryant K, White RT, Protter A: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993, 268:11811-11816
29. Nicholson A, Pearce SFA, Silverstein R: Oxidized LDL binds to CD36 on human monocyte-derived macrophages, and transfected cell lines: evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb 1995, 15:269-275
30. Nicholson AC, Hajjar DP, Silverstein RL: Effect of anti-CD36 antibodies on binding of oxidized LDL to CD36-transfected cells. Leukocyte Typing V: White Cell Differentiation Antigens. Edited by SF Schlossman, L Boumsell, W Gilks, JM Havlan, T Kishimoto, C Movimoto, J Ritz, RL Silverstein, TA Springer, TF Tedder, RF Todd. Oxford, England, Oxford University Press, 1995, pp 1278-1280
31. Han J, Hajjar DP, Febbraio M, Nicholson AC: Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem 1997, 272: 21654-21659
32. Villanova JG, Lucenda J, Arcas N, Engel A: Increased expression of scavenger receptor type I gene in human peripheral blood from hyperlipidemic patients determined by quantitative additive RT-PCR. Biochim Biophys Acta 1996, 1300:135-141
33. Lowry O, Rosebrogh N, Farr A, Randall J: Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275
34. Bilheimer D, Eisenberg S, Levy R: The metabolism of very low density lipoprotein proteins: I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta 1972, 260:212-221
35. Goldstein J, Basu S, Brown M: Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 1983, 98: 241-260
36. Goldstein J, Ho Y, Basu S, Brown M: Binding site on macrophages that mediates the uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979, 76:333-337
37. Liao JK, Shin WS, Lee WY, Clark SL: Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995, 270:319-324
38. Ashkenas J, Penman M, Vasile E, Acton S, Freeman M, Krieger M: Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors. J Lipid Res 1993, 34:983-1000
39. Brown M, Goldstein J: A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47
40. Phillips M, McClean L, Stoudt G, Rothblat G: Mechanism of cholesterol efflux from cells. Atherosclerosis 1980, 36:409-422
41. Dawson P, Hofmann S, van de Westhuyzen D, Sudhof T, Brown M, Goldstein J: Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1. J Biol Chem 1988, 263:3372-3379
42. Yla-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Sarkioja T, Witztum JL, Steinberg D: Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 1991, 87:1146-1152
43. Naito M, Suzuki H, Mori T, Matsumoto A, Kodama T, Takahashi K: Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol 1992, 141:591-599
44. Mazzone T, Basheeruddin K, Poulos C: Regulation of macrophage apolipoprotein E gene expression by cholesterol. J Lipid Res 1989, 30:1055-1063
45. Harai A, Kino T, Tokinagra K, Tahara K, Tamura Y, Yoshida S: Regulation of sterol carrier protein 2 (SCP2) in rat peritoneal macrophages during foam cell development: a key role for free cholesterol content. J Clin Invest 1994, 94:2215-2223
46. Rogers K, Hoover R, Castellot J, Robinson J, Karnovsky M: Dietary cholesterol-induced changes in macrophage characteristics: relationship to atherosclerosis. Am J Pathol 1986, 125:284-291
47. Fan J, Yamada T, Tokunaga O, Watanabe T: Alterations in the functional characteristics of macrophages induced by hypercholesterolemia. Virchows Arch B Cell Pathol 1991, 61:19-27
48. Montgomery R, Cohn Z: Endocytic and secretory repertoire of the lipid-loaded macrophage. J Leukocyte Biol 1989, 45:129-138
49. Lusis AJ, Navab M: Lipoprotein oxidation and gene expression in the artery wall - new opportunities for pharmacologic intervention in atherosclerosis. Biochem Pharmacol 1993, 46:2119-2126
50. Bochkov VN, Tkachuk VA, Hahn AWA, Bernhardt J, Buhler FR, Resink TJ: Concerted effects of lipoproteins and angiotensin-II on signal transduction processes in vascular smooth muscle cells. Arterioscler Thromb 1993, 13:1261-1269
51. Berliner J, Territo M, Sevanian A, Ramin S, Kim J, Bamshad B, Esterson M, Fogelman A: Minimally modified low density lipoproteins stimulates monocyte endothelial interactions. J Clin Invest 1990, 85: 1260-1266
52. Fei HH, Berliner JA, Parhami F, Drake TA: Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler Thromb 1993, 13:1711-1717
53. Cushing S, Berliner J, Valente A, Territo M, Navab M, Parhami F, Gerrity R, Schwartz C, Fogelman A: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990, 87:5134-5138
54. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA: Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 1993, 92:471-478
55. Terkeltaub R, Banka CL, Solan J, Santoro D, Brand K, Curtiss LK: Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with t-lymphocyte chemotactic activity. Arterioscler Thromb 1994, 14:47-53
56. Yui S, Sasaki T, Miyazaki A, Horiuchi S, Yamazaki M: Induction of murine macrophage growth by modified LDLs. Arterioscler Thromb 1993, 13:331-337
57. Sakai M, Miyazaki A, Hakamata H, Sasaki T, Yui S, Yamazaki M, Shichiri M, Horiuchi S: Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem 1994, 269:31430-31435
58. Watson A, Navab M, Hama S, Sevanian A, Prescott S, Stafforini D, McIntyre T, Du B, Fogelman A, Berliner J: Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 1995, 95:774-782
59. Kume N, Cybulsky M, Gimbrone M: Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human, and rabbit arterial endothelial cells. J Clin Invest 1992, 90:1138-1144
60. Hamilton T, Major J, Chisolm G: The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent. J Clin Invest 1995, 95:2020-2027
61. Andalibi A, Liao F, Imes S, Fogelman A, Lusis A: Oxidized lipoproteins influence gene expression by causing oxidative stress and activating the transcription factor NF-kappa B. Biochem Soc Trans 1993, 21:651-655
62. Aftring R, Freeman M: Structure of the murine scavenger receptor gene and evaluation of sequences that regulate expression in the macrophage cell line, P388D. J Lipid Res 1995, 36:1305-1314